ATE57948T1 - Lichtinduziertes toeten von karzinomzellen. - Google Patents

Lichtinduziertes toeten von karzinomzellen.

Info

Publication number
ATE57948T1
ATE57948T1 AT86302602T AT86302602T ATE57948T1 AT E57948 T1 ATE57948 T1 AT E57948T1 AT 86302602 T AT86302602 T AT 86302602T AT 86302602 T AT86302602 T AT 86302602T AT E57948 T1 ATE57948 T1 AT E57948T1
Authority
AT
Austria
Prior art keywords
light
carcinoma cells
induced killing
chromophore
mitochondria
Prior art date
Application number
AT86302602T
Other languages
English (en)
Inventor
Allan Oseroff
John A Parrish
James Foley
Louis Cincotta
Original Assignee
Gen Hospital Corp
Rowland Science Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Rowland Science Inst filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE57948T1 publication Critical patent/ATE57948T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86302602T 1985-04-08 1986-04-08 Lichtinduziertes toeten von karzinomzellen. ATE57948T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/720,711 US4651739A (en) 1985-04-08 1985-04-08 Light-induced killing of carcinoma cells
EP86302602A EP0226264B1 (de) 1985-04-08 1986-04-08 Lichtinduziertes Töten von Karzinomzellen

Publications (1)

Publication Number Publication Date
ATE57948T1 true ATE57948T1 (de) 1990-11-15

Family

ID=24895006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302602T ATE57948T1 (de) 1985-04-08 1986-04-08 Lichtinduziertes toeten von karzinomzellen.

Country Status (6)

Country Link
US (1) US4651739A (de)
EP (1) EP0226264B1 (de)
JP (1) JP2505413B2 (de)
AT (1) ATE57948T1 (de)
CA (1) CA1338671C (de)
DE (1) DE3675348D1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63111886A (ja) * 1986-10-29 1988-05-17 呉羽化学工業株式会社 光ダイオ−ドを用いた癌治療装置
US5304113A (en) * 1986-11-21 1994-04-19 The Mcw Research Foundation, Inc. Method of eradicating infectious biological contaminants
US4962197A (en) * 1988-02-12 1990-10-09 Rowland Institute For Science Photo-inactivation of cancer cells
US4885366A (en) * 1988-06-08 1989-12-05 Eastman Kodak Company Novel selenium-containing merocyanine dyes
US4937344A (en) * 1988-06-08 1990-06-26 Eastman Kodak Company Novel sulfur-containing merocyanine dyes
US4906750A (en) * 1988-06-08 1990-03-06 Eastman Kodak Company Sulfoalkyl benzoxazoleinylidene butenylidene thiobarbituric acid derivatives
US5152760A (en) * 1989-03-17 1992-10-06 The General Hospital Corporation Non-invasive sclerostomy
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US5405369A (en) * 1994-01-25 1995-04-11 Medical College Of Ohio Photochemical ablation of gastro-intestinal tissue for augmentation of an organ
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
US5885557A (en) * 1996-02-08 1999-03-23 Estee Lauder Inc. Compositions useful in the phototherapeutic treatment of proliferative skin disorders
US6416531B2 (en) * 1998-06-24 2002-07-09 Light Sciences Corporation Application of light at plural treatment sites within a tumor to increase the efficacy of light therapy
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
WO2000016806A1 (en) * 1998-09-17 2000-03-30 Nippon Kayaku Kabushiki Kaisha Remedies for photochemotherapy
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
EP1187659A1 (de) 1999-04-27 2002-03-20 The General Hospital Corporation doing business as Massachusetts General Hospital Phototherapeutisches verfahren zur behandlung von akne
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
GB0002719D0 (en) * 2000-02-08 2000-03-29 Tissuemed Ltd Thermal ablation of tissue
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2001291260A1 (en) * 2000-08-16 2002-02-25 The General Hospital Corporation D/B/A Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US20020107281A1 (en) * 2000-09-22 2002-08-08 Photogen, Inc. Phototherapeutic and chemotherapeutic immunotherapy against tumors
EP1276734A1 (de) * 2001-04-02 2003-01-22 Theratechnologies Inc. Halogenierte rhodamine derivate und deren verwendungen
EP1610829B1 (de) 2003-04-04 2010-01-20 Tissuemed Limited Zusammensetzungen für die gewebeadhäsion
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
JP4876073B2 (ja) 2004-08-03 2012-02-15 ティシュームド リミテッド 組織接着性材料
JP2009525109A (ja) 2006-02-03 2009-07-09 ティシューメッド リミテッド 組織接着材料
ES2454974T3 (es) * 2007-06-27 2014-04-14 The General Hospital Corporation Aparato para la inhibición óptica de la terapia fotodinámica
GB201201641D0 (en) * 2012-01-31 2012-03-14 Univ Central Lancashire Process for dye production
US20150182518A1 (en) * 2012-10-26 2015-07-02 Canon Kabushiki Kaisha Cancer cell inhibitory drug and cancer stem-cell detection probe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE73573C (de) * Badische Anilin- und Sodafabrik in Ludwigshafen a. Rh Verfahren zur Ueberführung von dialkylirten Rhodaminen in höher alkylirte Farbstoffe
US2251286A (en) * 1937-12-30 1941-08-05 Eastman Kodak Co Process of preparing oxatricarbocyanine dyes
US4181128A (en) * 1975-11-28 1980-01-01 Massachusetts Institute Of Technology Virus inactivation applicator and the like
US4336809A (en) * 1980-03-17 1982-06-29 Burleigh Instruments, Inc. Human and animal tissue photoradiation system and method
EP0087441A1 (de) * 1981-09-08 1983-09-07 Quentron Optics Pty. Ltd. Photostrahlungsverfahren und anordnung
JPS5940869A (ja) * 1982-08-31 1984-03-06 工業技術院長 レ−ザ光パルスを用いた癌の治療装置
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same

Also Published As

Publication number Publication date
US4651739A (en) 1987-03-24
CA1338671C (en) 1996-10-22
JPS61288872A (ja) 1986-12-19
EP0226264B1 (de) 1990-10-31
DE3675348D1 (de) 1990-12-06
EP0226264A1 (de) 1987-06-24
JP2505413B2 (ja) 1996-06-12

Similar Documents

Publication Publication Date Title
ATE57948T1 (de) Lichtinduziertes toeten von karzinomzellen.
AR227552A1 (es) Vidrio de baja densidad estable a los acidos,estable a la hidrolisis optico y oftalmico
DE3881368D1 (de) Optische anordnung mit drei zustaenden.
ES267291Y (es) "una disposicion de agujas de muestras multiples para determinar la entrada en una vena".
AR241106A1 (es) "metodo para fabricar una fibra optica".
FI791809A7 (fi) Obraennbart aemne
DK155185D0 (da) Optisk kvartglasfiber
IT1140999B (it) Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante
DK120379A (da) Optisk matrix-tastatur
DE3876221D1 (de) Absorption von schwefelwasserstoff.
DK106688A (da) Kvantebroendlaser med ladningsbaerertaethedsforoegelse
DE3676604D1 (de) Expression von epa in saeugetierzellen.
NO151405C (no) Bretteeske med et endelukkefelt ("pastilleske"), samt emne for en slik eske
NO880143L (no) Soetemiddel.
DE3585608D1 (de) Optische speicherungsstruktur.
DE68908988D1 (de) Elektrooptische Zelle.
DK702288D0 (da) Dihydropyranderivater
IT7922621A0 (it) Generatore d'armonica di luce laser.
SE8105057L (sv) Y-cirkulator enligt planledningsteknik
SU620835A1 (ru) Горелка дл атомно-абсорбционного спектрофотометра
LT2249B (lt) Aminoetanolio dariniu ar ju drusku gavimo budas
IT1199169B (it) Cella ottica contenente coloranti organici disciolti in agglomerato solido da utilizzare in cavita'laser come assorbitore saturabile ovvero materiale attivo
ES2038118T3 (es) Procedimiento para producir una disposicion de promotores, que son activos en estreptomicetos.
NO954360L (no) Nye celler inneholdende alkoholoksidase II regulatorisk område
IT1085220B (it) Poliuretani modificaati dotati di aumentata stabilita' alla luce

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee